The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases
Juan Molina Collada,1,2 Laura Trives,1 Isabel Castrejón1,2 1Department of Rheumatology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; 2Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, SpainCorrespondence: Isabel CastrejónDepartment of Rheumatology, Hospital Ge...
Guardado en:
Autores principales: | Molina Collada J, Trives L, Castrejón I |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2ca59bd0b69e4e789474af961e305358 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
por: Acar M, et al.
Publicado: (2018) -
Patterns of Response to Different Treatment Strategies in Seropositive Rheumatoid Arthritis Patients in a Tertiary Hospital in South‐Western Saudi Arabia: A Retrospective Study
por: AlOmair M, et al.
Publicado: (2021) -
A rare case of suicidal ideation related to Adalimumab use
por: Jafri F, et al.
Publicado: (2018) -
Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017) -
Methotrexate-Related Liver Cirrhosis in Psoriatic Arthritis: A Case Report and Review of the Literature
por: Maria-Loukia Koutsompina, et al.
Publicado: (2021)